• Pharma Mar appointed Elena Calleja Crespo as group chief financial officer, effective January 1, 2027.
• She succeeds María Luisa de Francia Caballero, who retires December 31, 2026, following 39 years with the group.
• Calleja Crespo has over 35 years of financial experience, including 18 years as CFO of the Oncology Business Unit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Mar SA published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.